Dr. Richard Huganir is a Professor and Director of the Solomon H. Snyder Department of Neuroscience at the Johns Hopkins University School of Medicine and Co-Director of the Johns Hopkins Medicine Brain Science Institute.Ā He has joint appointments in the Department Biological Chemistry and the Department of Pharmacology.Ā Dr. Huganir completed ...
August 2, 2017
2022 Patients with Alzheimerās disease (AD) present with a disease-dependent increase in the brain expression of a small glial-derived secreted protein named SFRP1, which interacts with harmful amyloid products (among the culprit of the pathology) and downregulates an enzyme that prevents their generation. Neutralization of SFRP1 activity in mice counteracts several ...
November 4, 2020
State of the Mind research presentations are private gatherings of donors and prospective donors who come together to hear from a researcher about Alzheimerās disease and the role Cure Alzheimerās Fund is playing in eradicating itāfunding research that leads to preventing, slowing or reversing the diseaseās progression. These events highlight ...
November 8, 2017
June 18, 2024
Early in his career, Dr. Tanzi worked with Dr. James Gusella to discover the first human genetic markers and use them to find a disease gene (Huntingtonās disease). He went on to first discover the amyloid precursor protein (APP) gene, the first Alzheimerās disease (AD) gene, and he co-discovered the ...
July 20, 2016
Learn about the rate of occurrence, and costs, impacting the US
September 24, 2017
Joyce Heyne Day, 86, of Lambertville, MI, beloved wife, mother, grandma,Ā and friend, passed away Friday, August 26, 2022, at her home. TheĀ daughter of Frank Jacob and Leota Harder Heyne, she was born onĀ August 14, 1936, and raised in Toledo, OH. She married Charles (Charlie)Ā Day on August 5, 1961, and together ...
October 25, 2022
Founder of Greenhill & Company Robert F. Greenhill is the Founder of Greenhill & Co., an investment banking firm. He was formerly Chairman and Chief Executive of Smith Barney and, prior to that, President of Morgan Stanley Group Inc. He graduated from Harvard Graduate School of Business Administration with high distinction as ...
September 19, 2017
Women are twice as likely to develop late-onset Alzheimerās disease (AD) as men, often attributed to women’s longevity. Recent evidence has emerged suggesting that gender-specific risk factors may drive this difference in addition to a longer lifespan. Attention has now shifted towards identifying the factors that put women at higher ...
October 23, 2020
Cure Alzheimerās Fund co-founder Henry McCance has been invited to join the Alzheimerās Study Group (ASG). The private, non-partisan group will be working hard through this year to form a national strategy to deal effectively with the growing tragedy of Alzheimerās disease. Co-chaired by former Speaker of the House and Founder ...
December 18, 2007
